BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 18060683)

  • 1. Tumor size and nephron-sparing surgery: does it still matter?
    Bensalah K; Crépel M; Patard JJ
    Eur Urol; 2008 Apr; 53(4):691-3. PubMed ID: 18060683
    [No Abstract]   [Full Text] [Related]  

  • 2. Positive margins after nephron-sparing surgery for renal cell carcinoma: long-term follow-up of patients on active surveillance.
    Lopez-Costea MA; Fumadó L; Lorente D; Riera L; Miranda EF
    BJU Int; 2010 Sep; 106(5):645-8. PubMed ID: 20067450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nephron-sparing surgery in renal cell carcinoma: did we sacrifice too many kidneys in the past?
    Fornara P
    Eur Urol; 2007 Jun; 51(6):1475-6. PubMed ID: 17287074
    [No Abstract]   [Full Text] [Related]  

  • 4. Predictive factors for ipsilateral recurrence after nephron-sparing surgery in renal cell carcinoma.
    Bernhard JC; Pantuck AJ; Wallerand H; Crepel M; Ferrière JM; Bellec L; Maurice-Tison S; Robert G; Albouy B; Pasticier G; Soulie M; Lopes D; Lacroix B; Bensalah K; Pfister C; Thuret R; Tostain J; De La Taille A; Salomon L; Abbou C; Colombel M; Belldegrun AS; Patard JJ
    Eur Urol; 2010 Jun; 57(6):1080-6. PubMed ID: 20188458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nephron-sparing surgery versus radical nephrectomy in the treatment of intracapsular renal cell carcinoma up to 7cm.
    Antonelli A; Cozzoli A; Nicolai M; Zani D; Zanotelli T; Perucchini L; Cunico SC; Simeone C
    Eur Urol; 2008 Apr; 53(4):803-9. PubMed ID: 18036730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rationale for total nephrectomy for suspected renal cell carcinoma.
    Marsh CL; Lange PH
    Semin Urol Oncol; 1995 Nov; 13(4):273-80. PubMed ID: 8595551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment trends for stage I renal cell carcinoma.
    Cooperberg MR; Mallin K; Kane CJ; Carroll PR
    J Urol; 2011 Aug; 186(2):394-9. PubMed ID: 21679982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nephron sparing surgery is a feasible and efficient treatment of T1a renal cell carcinoma in kidney transplant: a prospective series from a single center.
    Chambade D; Meria P; Tariel E; Vérine J; De Kerviler E; Peraldi MN; Glotz D; Desgrandchamps F; Mongiat-Artus P
    J Urol; 2008 Nov; 180(5):2106-9. PubMed ID: 18804233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nephron-sparing surgery is still controversial for patients with renal cell carcinoma and normal contralateral kidney: risks predictable by AgNOR counts in satellite lesions.
    Kobayashi M; Hashimoto S; Tokue A
    Mol Urol; 2000; 4(1):21-9. PubMed ID: 10851303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Editorial comment on: Positive surgical margin appears to have negligible impact on survival of renal cell carcinomas treated by nephron-sparing surgery.
    Eggener S
    Eur Urol; 2010 Mar; 57(3):472. PubMed ID: 19359087
    [No Abstract]   [Full Text] [Related]  

  • 11. Editorial comment on: Positive surgical margin appears to have negligible impact on survival of renal cell carcinomas treated by nephron-sparing surgery.
    Russo P
    Eur Urol; 2010 Mar; 57(3):472-3. PubMed ID: 19359086
    [No Abstract]   [Full Text] [Related]  

  • 12. Nephron-sparing surgery versus radical nephrectomy for kidney tumors: benefits and limitations.
    Roos FC; Thomas C; Hampel C; Thüroff JW
    Expert Rev Anticancer Ther; 2011 Jun; 11(6):805-8. PubMed ID: 21707272
    [No Abstract]   [Full Text] [Related]  

  • 13. Nephron sparing surgery for renal cell carcinoma.
    Abu Ghazaleh LA; Shunaigat AN
    Saudi J Kidney Dis Transpl; 2011 May; 22(3):557-60. PubMed ID: 21566321
    [No Abstract]   [Full Text] [Related]  

  • 14. Debulking nephrectomy in metastatic renal cancer.
    Flanigan RC
    Clin Cancer Res; 2004 Sep; 10(18 Pt 2):6335S-41S. PubMed ID: 15448027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Choice of operation for clinically localized renal tumor.
    Nguyen CT; Campbell SC; Novick AC
    Urol Clin North Am; 2008 Nov; 35(4):645-55; vii. PubMed ID: 18992618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can emerging level 1 evidence "discourage" elective nephron-sparing surgery for small renal tumors?
    Terrone C; Volpe A
    Eur Urol; 2011 Apr; 59(4):553-5. PubMed ID: 21239104
    [No Abstract]   [Full Text] [Related]  

  • 17. Long-term outcomes after nephron sparing surgery for renal cell carcinoma larger than 4 cm.
    Peycelon M; Hupertan V; Comperat E; Renard-Penna R; Vaessen C; Conort P; Bitker MO; Chartier-Kastler E; Richard F; Rouprêt M
    J Urol; 2009 Jan; 181(1):35-41. PubMed ID: 19012929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Re: Steiner T, Knels R, Schubert J. Prognostic significance of tumor size in patients after tumour nephrectomy for localised renal cell carcinoma. Eur Urol 46;2004:327-30.
    Bogdanovic J
    Eur Urol; 2005 Feb; 47(2):266-7. PubMed ID: 15661427
    [No Abstract]   [Full Text] [Related]  

  • 19. Editorial comment.
    Russo P
    Urology; 2010 Feb; 75(2):275-6; author reply 276. PubMed ID: 20152477
    [No Abstract]   [Full Text] [Related]  

  • 20. Outcomes following partial nephrectomy by tumor size.
    Crispen PL; Boorjian SA; Lohse CM; Sebo TS; Cheville JC; Blute ML; Leibovich BC
    J Urol; 2008 Nov; 180(5):1912-7. PubMed ID: 18801543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.